Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction Ischemic stroke is a prevalent disease that has a broad spectrum of health implications, including a high morbidity and mortality rate. Approximately 610 000 cases of ischemic strokes are attributed to first-time stroke in the United States.1 Stroke prevention strategies focus on both primary and secondary preventions—particularly for individuals with modifiable risk factors such as smoking, hypertension, obesity, hyperlipidemia, and/or diabetes.
Ischemic stroke represents one of the leading causes of death and disability in both the United States and abroad, particularly for patients with prior ischemic stroke or transient ischemic attack (TIA). A quintessential aspect of secondary stroke prevention is the use of different pharmacological agents, mainly antiplatelets and anticoagulants. Antiplatelets and anticoagulants exhibit their effect by blocking the activation pathways of platelets and the coagulation cascade, respectively.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.